Galmed Pharmaceuticals (EOCN) EPS (Diluted) (2013 - 2026)
Galmed Pharmaceuticals' EPS (Diluted) was $23.40 in Q2 2026, up 9.1% from $21.44 a year earlier.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) EPS (Diluted) (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Galmed Pharmaceuticals' EPS (Diluted) was -$26.66 through Jun 30, 2026; for FY2025, it came in at -$2.72.
- In earlier years, EPS (Diluted) was -$3.25 in FY2024, $239.60 in FY2023 (-76.6%), $1,023 in FY2022 (-46.2%) and $1,901 in FY2021 (-2.4%).
- The Q2 2026 figure marks the highest quarterly EPS (Diluted) since Q3 2024.
- Compared with a year earlier, EPS (Diluted) was higher in 1 of the last four quarters, with an average decline of 33.1%.
- The best year-over-year quarter for EPS (Diluted) over five years was Q3 2021 (growth of 10.8%); the worst was Q3 2025 (a decline of 75.5%).
- Per Business Quant data, EOCN's EPS (Diluted) in the three quarters before Q2 2026 was -$16.42 (Q1 2026), -$49.91 (Q4 2025) and $16.26 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | 23.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.40 |
| Mar 31, 2026 | -16.42 |
| Dec 31, 2025 | -49.91 |
| Sep 30, 2025 | 16.26 |
| Jun 30, 2025 | 21.44 |
| Mar 31, 2025 | -9.49 |
| Dec 31, 2024 | -40.27 |
| Sep 30, 2024 | 66.35 |
| Jun 30, 2024 | 38.79 |
| Mar 31, 2024 | -44.20 |
| Dec 31, 2023 | 69.88 |
| Sep 30, 2023 | 84.36 |
| Jun 30, 2023 | 91.24 |
| Mar 31, 2023 | -104.81 |
| Dec 31, 2022 | 151.15 |
| Sep 30, 2022 | 313.20 |
| Jun 30, 2022 | 218.59 |
| Mar 31, 2022 | -359.62 |
| Dec 31, 2021 | 436.25 |
| Sep 30, 2021 | 521.99 |
API Access
Galmed Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();